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Mycobacterium avium subsp. paratuberculosis (MAP) is the causative pathogen of
chronic granulomatous enteropathy (Johne’s disease) in animals, and has been focused
on its association with various autoimmune diseases in humans, including Crohn’s
disease. The discovery of novel mycobacterial antigens and exploring their role in
host immunity can contribute to the advancement of effective defense strategies
including vaccines and diagnostic tools. In a preliminary study, we identified cellular
extract proteins of MAP that strongly react with the blood of patients with Crohn’s
disease. In particular, MAP1981c, a putative nucleic acid-binding protein, showed high
expression levels and strong reactivity to IgG and IgM in the sera of patients. Here, we
investigated the immunological features of MAP1981c and focused on its interaction
with dendritic cells (DCs), confirming its immunomodulatory ability. MAP1981c was
shown to recognize Toll-like receptor (TLR) 4, and induce DC maturation and activation
by increasing the expression of co-stimulatory (CD80 and CD86) and MHC class I/II
molecules and the secretion of pro-inflammatory cytokines (IL-6, IL-1β, and TNF-α)
in DCs. This DC activation by MAP1981c was mediated by downstream signaling of
TLR4 via MyD88- and TRIF-, MAP kinase-, and NF-κB-dependent signaling pathways. In
addition, MAP1981c-treated DCs activated naïve T cells and induced the differentiation
of CD4+ and CD8+ T cells to express T-bet, IFN-γ, and/or IL-2, but not GATA-3 and
IL-4, thus indicating that MAP1981c contributes to Th1-type immune responses both
in vitro and in vivo. Taken together, these results suggest that MAP1981c is a novel
immunocompetent antigen that induces DCmaturation and a Th1-biased response upon
DC activation, suggesting that MAP1981c can be an effective vaccine and diagnostic
target.
Keywords: Mycobacterium avium subsp. paratuberculosis, MAP1981c, Crohn’s disease, dendritic cells, Th1
immune response
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INTRODUCTION
Mycobacterium avium subsp. paratuberculosis (MAP)
causes Johne’s disease, which is a form of chronic gastroenteritis
in ruminants (Motiwala et al., 2006). This disease is difficult to
eradicate once it occurs in herds because of the shedding of MAP
through feces and milk and the propagation of the infection
during the latency period (Harris and Barletta, 2001). Recently,
MAP has received increasing attention because it might cause
zoonosis through infected food, such as meat and dairy products
and several studies have reported a link between MAP infection
and the pathogenesis of multiple human autoimmune diseases
including type 1 diabetes mellitus, Hashimoto’s thyroiditis,
multiple sclerosis, sarcoidosis, Blau syndrome, and Crohn’s
disease (Quayle et al., 1992; Naser et al., 2004; Sechi et al., 2008;
D’amore et al., 2010; Dow and Ellingson, 2010; Mameli et al.,
2016). To date, the association of this pathogen with human
diseases has been found by isolatingMAP or detecting antibodies
specific to MAP from the tissue samples of patients (Naser et al.,
2000a,b, 2004; Sechi et al., 2005; D’amore et al., 2010; Dow and
Ellingson, 2010; Cossu et al., 2011). Crohn’s disease, which is a
chronic inflammatory bowel disease in humans, is distinct from
intestinal tuberculosis, though the clinical manifestations of
the two diseases can be similar. When acid-fast staining bacilli
were found in the intestine tract, M. tuberculosis or M. bovis, as
agents of intestinal tuberculosis, were suspected; on the other
hand, Crohn’s disease is immunologically and pathologically
different from intestinal tuberculosis, and therefore should be
differentially diagnosed and treated (Sharma et al., 2016). Even
though it has been suggested that MAP is a possible causative
agent of Crohn’s disease and/or other autoimmune diseases, this
hypothesis has not been fully validated yet, mainly because of
the slow growth and the difficulty in culturing this pathogen
(Chamberlin et al., 2001).
MAP1981c, one of the cellular extract (CE) proteins isolated,
is a protein with unknown function that showed a high
expression level and strong immunoreactivity toward both
IgG and IgM of serum from patients with Crohn’s disease
(unpublished data). In a study from Facciuolo and colleagues,
MAP1981c induced a strong immune response in the Peyer’s
patch of the ileum, which is the main entrance site of MAP,
and reacted with the serum of calves challenged with MAP
(Facciuolo et al., 2016). Interestingly, we identified MAP1981c
as a CE protein, while Facciuolo and colleagues reported
it as a culture filtrate (CF) protein highly reactive to the
blood of cattle with Johne’s disease (Facciuolo et al., 2013).
According to Facciuolo et al. the proteins identified by their MAP
secretome analysis partially overlapped with MAP proteomes
from cytoplasmic and membrane-enriched protein fractions
identified in other studies. The authors suggested, therefore,
that the methodologies used in cytoplasmic proteomes, cell wall
proteomes, and secretomes allow the separation of unique MAP
subproteomes with small overlaps. In addition, MAP1981c is an
abundant protein that can be secreted or expressed in the CE
fraction and is likely seroreactive for Johne’s or Crohn’s disease;
therefore, it is worth studying this molecule as an immunological
antigen.
MAP1981c is a hypothetical 245 amino acid (aa) protein
with a C4-type zinc ribbon domain near the C-terminal
region (aa 204–237) composed of two beta-strands acting as
a support for two zinc knuckles, and two pairs of cysteines
constituting two zinc knuckles located in a preserved sharp
beta-turn, which is an arrangement that promotes the tetrahedral
coordination of divalent Zn ions (http://pfam.xfam.org/
family/zf-RING_7). Structural modeling has shown that
this domain can bind to nucleic acids: therefore MAP1981c
might be a nucleic acid-binding protein (Rigden, 2011).
MAP1981c shows amino acid similarity with other predicted
nucleic acid-binding proteins containing a Zn-ribbon from
other mycobacteria such as Mav2210 (from M. avium 104,
99% similarity), MLM1938 (from M. lepraemurium, 96%
similarity), Mb2254c (fromM. bovis AF2122/97, 90% similarity),
Rv2229c (from M. tuberculosis H37Rv, 90% similarity), and
ML1638 (from M. leprea TN, 80% similarity), as well
as with proteins from different bacterial species such as
Rhodococcus sp. (67% similarity), and Nocardiodes sp. (66%
similarity).
Although the function of MAP1981c is unknown, as a nucleic
acid-binding protein it might be involved in DNA synthesis
or replication. Salmonella is a gram-negative bacterium distinct
from MAP; however, like MAP, this bacterium is also an
intracellular pathogen and is exposed to the nitrosative stress
in phagocytic cells (i.e., macrophages) where DNA replication
is inhibited by DNA-binding Zn-metalloproteins involved in
Zn mobilization (Schapiro et al., 2003). Mycobacterium is
exposed to stressful environments, such as the hypoxic and
acidic environment, nutrient deficiency, and oxidative stress
when it infects the host; it is known to survive in a stressful
environment through its slow replication and metabolism.
Therefore, genes associated with these processes are thought
to be related to the pathogenicity of mycobacteria (Via et al.,
2008; Wang et al., 2015). In this study, we investigated
MAP1981c, a putative nucleic acid-binding protein. We analyzed
the immunological features of MAP1981c and focused on
its potential interaction with dendritic cells (DCs). Our data
indicate that this protein might be useful for vaccine target
or early diagnosis of infection through its immunomodulation
ability.
MATERIALS AND METHODS
Animals
Wild-type (WT), OT-I T-cell receptor transgenic (TCR), OT-II
TCR transgenic, Toll-like receptor 2 (TLR2) knockout (TLR2
K/O), TLR4 K/O, myeloid differentiation primary response
protein (MyD88) K/O, and Toll/IL-1R domain-containing
adaptor inducing IFNβ (TRIF) K/O mice (All mice are
C57BL/6 background) were purchased at 6–7 weeks of age
from Jackson Laboratory (Bar Harbor, ME, USA). All animals
were raised in a specific pathogen-free environment, and
used in this study according to the regulations set forth
by the Institutional Animal Care and Use Committee of
the Yonsei University Health System (Permit number: 2015-
0203).
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Reagents and Antibodies
Recombinant mouse granulocyte-macrophage colony
stimulating factor (GM-CSF) and interleukin (IL)-4
were purchased from JW CreaGene (Daegu, Korea).
Lipopolysaccharide (LPS, from Escherichia coli O111:B4) were
purchased from Invivogen (San Diego, CA, USA). The annexin
V/propidium iodide (PI) kit was purchased from BD Bioscience
(San Diego, CA, USA). ELISA kits for TNF-α, IL-6, IL-1β,
IL-4, IL-12p70, and IL-10 were purchased from eBioscience
(San Diego, CA, USA). The OT-I (OVA257−264) and OT-II
(OVA323−339) peptides were synthesized by Abfrontier (Seoul,
Korea). Fluorescein-conjugated antibodies (Abs) to, MHC-I,
MHC-II, T-bet, and GATA-3 were purchased from eBioscience.
Fluorescein-conjugated Abs to, CD11c, CD80, CD86, TNF-α, IL-
12p70, IL-10, CD4, IFN-γ, IL-4, and CD8α were purchased from
BD Bioscience. Anti-phosphorylated ERK1/2, -phosphorylated
JNK, -phosphorylated p38, -phosphorylated IκB-a, IκB-a,
NF-κB (p65), and lamin B were purchased from Santa Cruz
Biotechnology (CA, USA). Anti-β-actin mAb (AC-15) and
FITC-dextran (molecular mass, 40 kDa) were purchased from
Sigma (St. Louis, MO, USA). All the pharmacological inhibitors
were purchased from Calbiochem (San Diego, CA, USA).
Expression and Purification of MAP1981c
Protein
The MAP1981c gene was amplified from genomic DNA from
MAP ATCC 19698 and the following primers: forward primer;
the Nde I site is underlined, 5′-CGCCATATGAAAGCCGAT
GTAGCACAGCAG-3′ and reverse primer; the Hind III site
is underlined, 5′-CCCAAGCTTCTGACCGGACCCCTTG
ACC-3′. The PCR-amplified full-length open reading frame
(ORF) of MAP1981c gene was inserted into the plasmid
pGEMT Easy Vector and sequences of MAP1981c gene in
plasmid were confirmed. Next, the MAP1981c gene was
cloned into the pET-22b (+) vector (Novagen, Madison,
WI, USA) and then the clone was transformed into E. coli
BL21 cells. The recombinant MAP1981c was expressed
after induction with 1mM isopropyl-β-D-thio-galactoside
(IPTG) at 37◦C for 6 h and then lysed and sonicated in lysis
buffer supplemented with 20mM Tris-HCl (pH 8.0), O,5M
Nacl, 20mM imidazole, 1mM dithiothreitol, and 1mM
phenylmethylsulfonyl fluoride. The recombinant proteins were
purified by using an immobilized nickel-chelate (Ni-NTA)
column (Invitrongen, Carlsbad, CA, USA) in accordance with
the manufacturer’s instruction. Endotoxin contamination was
removed from the recombinant MAP1981c by incubation
with polymyxin B (PMB)-agarose (Sigma) for 8 h at 4◦C. Also,
Residual LPS in the MAP1981c preparation was measured
by an Limulus Amebocyte Lysate (LAL) assay (Lonza, Basel
Switzerland) and was <7 pg/mL (<0.1 UE/mL) in MAP1981c
preparations.
Generation of Bone Marrow-Derived
Dendritic Cells (BMDCs)
Whole bone marrow cells from C57BL/6 mice were lysed of
Red Blood Cells (RBCs) using RBC Lysing buffer (Sigma) and
then cells were maintained in 6-well plates (1 × 106 cells/mL;
2 mL/well) and cultured at 37◦C in the presence of 5% CO2,
using complete-RPMI 1640 (c-RPMI 1640) supplemented with
100 U/mL penicillin/streptomycin (Lonza, Basel, Switzerland),
10% fetal bovine serum (Lonza), GM-CSF (20 ng/mL) and IL-4
(0.5 ng/mL). Culture plates were added with 1mL c-RPMI 1640
media per well on 3 and 6 days of culture. After 8 day culture,
cells were harvested, stained with anti-CD11c mAb. Over 90% of
the cells expressed CD11c.
Annexin V and PI Staining
BMDCs were treated for 24 h with LPS (100 ng/mL) or
MAP1981c (1, 2, 5µg/mL), respectably. After 24 h treatment,
cells were harvested and stained with Annexin V and PI
according to the manufacturer’s instructions. Datas were
collected on a FACSverse (BD Bioscience) and analyzed using
FlowJo software (TreeStar).
Analysis of Cell Surface Molecules
Expression
Non-treated DCs (Con), LPS-treated DCs, and MAP1981c-
treated DCs were first blocked with Fc Blocker (anti-CD16/32;
ebioscience) for 20min at room temperature and then stained
with anti-CD11c, anti-CD80, anti-CD86, anti-MHC-I, and anti-
MHC-II Abs for 20min at room temperature. Expression of
surface molecules in DCs was measured by flow cytometry and
FlowJo software.
Cytokine Measurements
The cytokine concentrations were determined using ELISA kit
following the manufacturer’s instructions.
LPS Decontamination of Recombinant
MAP1981c Through Polymyxin B Binding,
Boiling, and Proteinase K Treatment
For pretreatment with polymyxin B (PMB, Sigma), LPS and
MAP1981c were incubated in a medium containing 10µg/mL
of PMB for 1 h at RT. For heat-denaturation, LPS or MAP1981c
were incubated at 100◦C for 1 h. For digestion of proteinase K
(PK), LPS or MAP1981c were incubated along with 10µg/mL
soluble PK followed by heating for 20min at 100◦C to deactivate
the enzyme, and subsequently added to DCs. After 24 h,
cytokine levels in the supernatant of DCs were analyzed using
ELISA.
Analysis of Antigen Uptake Ability
Non-treated DCs (Con), LPS-treated DCs and MAP1981c-
treated DCs were equilibrated at 37or 4◦C for 30min and then
cells treated with fluorescein-conjugated dextran (0.5 mg/mL).
Cold PBS was added to stop the reaction. The cells were stained
with anti-CD11c Ab and then CD11c+Dextran+ cells were
measured by flow cytometry.
Intracellular Cytokine Staining in DCs
On the 24 h after LPS or MAP1981c treatment in presence of
GolgiPlug (BD Bioscience), cells were harvested and stained with
anti-CD11c for 20min at room temperature. The cells were fixed
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and permeabilized using Cyofix/Cytoperm kit (BD Bioscience)
according to the manufacturer’s instructions. Intracellular
cytokine levels (TNF-α, IL-12p70, and IL-10) were detected with
fluorescein-conjugated antibodies in a permeabilization buffer.
Expression Levels of intracellular TNF-α, IL-12p70, and IL-10
in CD11c+ cells were analyzed by flow cytometry and FlowJo
software.
T Cell Proliferation Assay
For T cells proliferation assay using OVA system, DCs were
treated for 24 h with LPS or MAP1981c and then cells treated
for 1 h with OT-I peptide (OVA323−339) and OT-II (OVA257−264).
CD4+ and CD8+ T cells separated from OVA-specific TCR-
transgenic mice were stained with 1µM CFSE (with 5% FBS in
RPMI, Invitrogen, Carlsbad, CA) for 10min at 37◦C water bath.
Next, no OVA-treated and OVA-treated DCs (1 × 105 cells/well)
were co-cultured with CFSE-labeled CD4+ and CD8+ T cells
(5 × 105 cells/well) at an BMDC:T cell of 1:5. After 3 days
co-culture, T cells were stained with anti-CD4 and CD8 Abs.
CFSE+CD4+ and CFSE+CD8+ T cells were analyzed by flow
cytometry and FlowJo software.
Immunoblotting Analyses
After stimulation with MAP1981c or LPS, cytosolic extracts
from DCs were isolated using 100 µL lysis buffer supplemented
with 50mM Tris-HCl (pH 7.5), 150mM NaCl, 1% Triton-
X100, 1mM EDTA, 50mM NaF, 30mM Na4PO7, 1mM
phenylmethanesulfonyl fluoride, 2µg/mL aprotinin, and 1mM
pervanadate. Nuclear extracts from DCs were isolated using
a Cellytic nuclear extraction kit (Sigma) according to the
manufacturer’s protocol. Immunoblotting was carried out as
previously described (Kim et al., 2013). Target protein epitopes
were labeled with primary Abs, and the results were visualized
using an ECL Advance Western Blotting Detection kit (GE
Healthcare, Little Chalfont, UK).
Confocal Laser Scanning Microscopy
DCs were incubated overnight on poly-L-lysine-coated glass
coverslipt. After treatment with MAP1981c or LPS for 1 h, DCs
were fixed in 4% paraformaldehyde, permeabilized in 0.1%Triton
X-100, blocked with 2% BSA in PBS plus 0.1% Tween-20 (PBS/T)
for 2 h, and incubated with 2% bovine serum albumin (BSA) in
PBS/T containing anti-p65mAb for 2 h at room temperature. The
cells were incubated with an FITC-conjugated secondary Ab in a
dark room for 1 h and stained with 1µg/mL DAPI for 10min
at room temperature. The cell morphology and fluorescence
intensity were observed by using a confocal laser scanning
microscope (FV1000, Olympus, Japan).
Analysis of Conventional DC and T Cell
Phenotype in Spleens of
MAP1981c-Injected Mice
The in vivo experiments for the activation of DC and T cells
via MAP1981c injection were designed as described previously
(Kim J. S. et al., 2015) and slightly modified. To analyze the
activation of DCs in MAP1981c-injected mice, mice from the
PBS and antigen groups were injected intravenously (IV) with
PBS and 5 mg/kg MAP1981c. After 24 h of injection, splenocytes
separated from PBS- or MAP1981c-injected mice were stained
with the Live/Dead (L/D) cell staining kit (Invitrogen, Life
Technologies, Naerum, Denmark), anti-CD11c, anti-CD8α, anti-
CD80, anti-CD86, anti-MHC-I, and anti-MHC-II Abs. The
expression of cell surface molecules in CD8α+CD11c+ and
FIGURE 1 | Cytotoxicity of recombinant MAP1981c protein. (A) Expression and purification of recombinant MAP1981c. (A, left panel) The recombinant MAP1981c
was induced in E. coli by use of IPTG. Lane M, molecular weight marker; Lane 1, cell lysate before the addition of IPTG; Lane 2, cell lysate at 24 h after IPTG induction.
(A, middle panel) The recombinant MAP1981c was purified by using Ni-NTA resin. The purified protein was subjected to SDS-PAGE. The gels were stained with
Coomassie brilliant blue. (A, right panel) The purified protein was subjected to immunoblotting analysis with mouse anti-His Ab (1:1,000). (B) Cytotoxicity of the
recombinant MAP1981c. The DCs were treated with MAP1981c (1, 2, or 5µg/mL), LPS (100 ng/mL), or an equal volume of PBS as a control (Con). After 24 h of
treatment, the cells were harvested and stained with annexin V and PI. The number in each quadrant indicated the percentage of positive cells. The results of one
representative experiment out of three experiments producing similar results are shown.
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CD8α−CD11c+ conventional DCs (cDCs) was analyzed by flow
cytometry. Next, to analyze the activation and polarization
of T cells in MAP1981c-injected mice, mice from the PBS
and antigen groups were injected IV with PBS and 5 mg/kg
MAP1981c. Three days later, they were injected with PBS
or 5 mg/kg MAP1981c again. Three days after the final
injection, splenocytes were cultured in plates coated with
Live/Dead, anti-CD3 mAb (0.5µg/mL), and anti-CD28 mAb
(0.5µg/mL) in the presence of GolgiPlug. After 12 h, cells
were harvested and stained with anti-CD3, anti-CD4, and anti-
CD8 for 30min at 4◦C, and subsequently, cells were fixed and
permeabilized using the Cyofix/Cytoperm kit. Following that,
cells were stained with anti-IFN-γ and anti-IL-4 mAbs for 30min
at RT. Also, non-stimulated splenocytes were directly fixed
and permeabilized using the Foxp3 Fixation/Permeabilization
working solution (eBioscience) according to the manufacturer’s
instructions. Following that, cells were stained with anti-T-bet
and anti-GATA-3 mAbs for 30min at RT. The cytokines and
FIGURE 2 | DC maturation induced by MAP1981c. The DCs were stimulated with MAP1981c (1, 2, or 5µg/mL), LPS (100 ng/mL) or an equal volume of PBS as a
control (Con) for 24 h. (A) Gating strategy for analysis of surface markers (CD80, CD86, MHC class I, and MHC class II) on stimulated CD11c+ DCs by using flow
cytometry. (B) The percentages (top panel) and mean fluorescence intensities (MFI) (bottom panel) calculated from histograms are indicated as the mean ± SD of
three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001 for the treatments compared with untreated DCs (Con).
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transcription factors induced by T cells were analyzed by flow
cytometry.
Statistical Analysis
Significant differences between samples were determined with
Tukey’s multiple comparison test and unpaired t-tests using
statistical software (GraphPad Prism Software, version 5;
GraphPad Software, San Diego, CA). The data in the graphs are
expressed as the means. ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001
were considered statistically significant.
RESULTS
MAP1981c Is Not Cytotoxic to DCs
The predicted molecular mass of MAP1981c is ∼26.95 kDa. We
confirmed this prediction by expressing recombinant MAP1981c
FIGURE 3 | Cytokine production by MAP1981c stimulation in DCs. (A) The DCs were stimulated with MAP1981c (1, 2, or 5µg/mL), LPS (100 ng/mL), or PBS (Con)
for 24 h and the culture supernatants were analyzed for the amounts of TNF-α, IL-6, IL-1β, L-12p70, and IL-10 by using quantitative ELISA. (B) Dot plots of
intracellular IL-12p70 and IL-10 in CD11c+ DCs. DCs were stimulated with MAP1981c (1, 2, or 5µg/mL), LPS (100 ng/mL) for 12 h in the presence of GolgiPlug. The
intracellular IL-12p70 and IL-10 levels were analyzed in CD11c+ DCs by flow cytometry. All bar graphs show the means ± SD of 3 samples. One representative plot
out of three independent experiments is shown; *p < 0.05, **p < 0.01, ***p < 0.001 for the treatments compared with untreated DCs (Con).
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followed by SDS-PAGE and western blotting assays (Figure 1A).
Importantly, Annexin V/PI staining followed by flow cytometry
analysis indicated that MAP1981c is not cytotoxic to DC, up to
concentrations of 5µg/mL MAP1981c (Figure 1B).
MAP1981c Induces Phenotypic Maturation
of DCs and Th1-Polarization
Next, we investigated whether MAP1981c can induce the DCs
maturation. Specifically, we analyzed the phenotypic maturation
of DCs by analyzing the expression levels of co-stimulatory
molecules (CD80 and CD86) and MHC class molecules (MHC-I
and MHC-II) that are DC maturation markers, in the presence
of MAP1981c (1, 2, or 5µg/mL) or lipopolysaccharide (LPS,
100 ng/mL, used as a positive control). As shown in Figure 2,
MAP1981c treatment significantly increased the expression of
CD80, CD86, MHC-I, and MHC-II is a dose-dependent way.
The cytokines produced by mature DCs are potent signaling
molecules. To determine the cytokines produced by MAP1981c-
treated DCs, we next analyzed the expression of pro- (TNF-α,
IL-6, and IL-1β) and anti-inflammatory (IL-10) cytokines, and
that of a Th1 polarizing cytokine (IL-12p70). We found that
MAP1981c strongly induced the expression of TNF-α, IL-6, IL-
1β, and IL-12p70 in a dose-dependent manner, and did not
affect the secretion of IL-10 (Figures 3A,B). We next confirmed
the absence of endotoxin or LPS contamination of MAP1981c
using the LAL assay (the endotoxin levels of MAP1981c are
shown in the Materials and Methods section), heat denaturation,
or treatment with PK or PMB. PMB treatment did not affect
MAP1981c-induced cytokine production in DCs, whereas it
significantly inhibited cytokine production in LPS-treated DCs
(Figure 4A). Also, heat-denatured MAP1981c (Figure 4B) and
co-treatment of DCs with MAP1981c and PK (Figure 4C) did
not induce the secretion of TNF-α, IL-6, and IL-1β. Taken
FIGURE 4 | Confirmation of no LPS contamination of the recombinant MAP1981c. (A) DCs were treated with MAP1981c (5µg/mL) and LPS (100 ng/mL) in presence
and absence of PMB. (B) DCs were treated with MAP1981c, LPS, boiled MAP1981c, and boiled LPS. (C) DCs were treated with MAP1981c and LPS in presence
and absence of PK. After 24 h treatment, the culture supernatants were analyzed for the amounts of TNF-α, IL-6, and IL-1β by using ELISA. All bar graphs show the
means ± SD of 3 samples. One representative plot out of three independent experiments is shown. The value of n. s. was defined as having no significant effect. The
value of ***p < 0.001 was considered to be statistically significant compared with MAP1981c-treated DCs or LPS-treated DCs.
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 7 June 2018 | Volume 8 | Article 206
Kim et al. MAP1981c-Activated DCs Induce Th1 Polarization
together, these results confirm that DC maturation is induced by
MAP1981c and is not due to endotoxin contamination.
MAP1981c Treatment Reduces Dextran
Uptake by Immature DCs
DC maturation is characterized by antigen uptake ability:
immature DCs exhibit high antigen uptake ability, while mature
DCs exhibit low ability (Drutman and Trombetta, 2010).
Therefore, we investigated antigen uptake ability during DC
maturation induced by MAP1981c. Specifically, we evaluated
the ability of DCs stimulated with various concentrations of
MAP1981c (1, 2, 5µg/mL) to uptake FITC-conjugated dextran
at 37◦C (Figure 5A), to detect positive cells, or 4◦C (Figure 5B),
to detect non-specific binding. Similar to the LPS-treated DCs,
MAP1981c-treated DCs showed reduced FITC-dextran uptake
ability compared with untreated DCs (Figure 5A). These results
indicate that MAP1981c results in DC maturation and reduce
antigen uptake.
TLR4 and Its Downstream Signaling Is
Required for DC Maturation Induced by
MAP1981c
Toll-like receptors (TLRs), such as TLR2 and TLR4, have
been reported to recognize MAP in the context of murine
macrophage and human PBMC activation (Ferwerda et al.,
2007). Thus, to examine whether these receptors are involved
in MAP1981c-induced DC maturation, the production of
cytokines and the expression of surface molecules in WT-, TLR2
K/O-, and TLR4 K/O-derived DCs following treatment with
MAP1981c were analyzed (Figure 6). We found that MAP1981c
induced the expression of surface molecules (Figure 6A) and
proinflammatory cytokine secretion (Figure 6B) in WT- and
FIGURE 5 | Endocytic activity induced by MAP1981c stimulation in DCs. The endocytic capacity was assessed at 37 (A) or 4◦C (B) by the flow cytometric analysis of
FITC-dextran uptake. The percentages of FITC-dextran-positive and CD11c+-positive cells are indicated. All bar graphs show the means ± SD of 3 samples. One
representative plot out of three independent experiments is shown; **p < 0.01, ***p < 0.001 for the treatments compared with untreated DCs (Con).
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FIGURE 6 | MAP1981c-induced DC maturation via TLR4 signaling. (A,B) WT-, TLR2 K/O, and TLR4 K/O-derived DCs were stimulated with MAP1981c (5µg/mL)
and LPS (100 ng/mL) for 24 h and analyzed for the expression of surface molecules (CD86 and MHC-II) and the production of pro-inflammatory cytokines (TNF-α,
IL-6, and IL-1β) by flow cytometry (A) and ELISA (B), respectively. (C) WT-, MyD88 K/O, and TRIF K/O-derived DCs were stimulated with MAP1981c (5µg/mL) and
LPS (100 ng/mL) for 24 h and analyzed for the production of TNF-α, IL-6, and IL-1β by ELISA. All bar graphs show the means ± SD of 3 samples. One representative
plot out of three independent experiments is shown; ***p < 0.001.
TLR2 K/O-derived DCs, but not in TLR4 K/O-derived DCs.
Further, to confirm the relevance of TLR4 adaptor molecules,
such as myeloid differentiation primary response protein
(MyD88) and Toll/IL-1R domain-containing adaptor inducing
IFNβ (TRIF) inMAP1981c-induced DCmaturation, we analyzed
the cytokine production in WT-, MyD88 K/O-, and TRIF K/O-
derived DCs. As a result, the induction of cytokine production by
MAP1981c treatment was significantly reduced in MyD88 K/O-
, and TRIF K/O-derived DCs compared with that in WT-DCs
(Figure 6C). These results indicate that TLR4/MyD88/TRIF-
mediated signals are key players in MAP1981c-induced DC
maturation.
MAP1981c Induces DC Maturation
Through Activation of the MAPKs and
NF-kB Signaling Pathways
The mitogen-activated protein kinases (MAPKs) and nuclear
factor kappa B (NF-kB) signaling pathways are essential for
the expression and secretion of cytokines by mature DCs
(Arrighi et al., 2001); however, the effect of MAP1981c on
these pathways is unknown. We therefore examined whether
MAP1981c could induce DCmaturation via theMAPKs and NF-
kB signaling pathways. We found that MAP1981c induced the
phosphorylation of MAPKs (ERK, JNK, and p38; Figure 7A),
phosphorylation and degradation of inhibitor of kB (IkB-α;
Figure 7B), and the nuclear translocation of p65 (Figures 7C,E).
Next, to confirm the role of these kinases in the DC maturation
induced by MAP1981c, we analyzed surface molecule expression
and cytokine production in DCs treated with MAPKs- and
NF-kB-specific pharmacological inhibitors. Co-treatment with
MAP1981c and these inhibitors significantly abolished the
expression of surface molecules (CD80 and CD86; Figure 8A)
and the production of pro-inflammatory cytokines (TNF-α, IL-
6, and IL-1β; Figure 8B) compared to MAP1981c treatment.
These results suggest that MAP1981c induces functional DC
maturation via the MAPKs and NF-kB signaling pathways.
MAP1981c-Treated DCs Promote Naïve T
Cell Proliferation and Favor Th1 Responses
The primary role of DC is to interact with naïve T cells and induce
T cell activation and differentiation (Lipscomb and Masten,
2002). Thus, we investigated the effect of DCs treated with
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FIGURE 7 | The activation of MAPK and NF-κB signal transduction induced by MAP1981c. DCs were stimulated with MAP1981c (5µg/mL) for various time points (0,
15, 30, and 60min) and then suspended in lysis buffer. Protein levels in cell lysate were evaluated by immunoblotting analysis. (A) Expressions of phospho-p38 (p-38),
non-phospho-p38 (p38), p-ERK, ERK, p-JNK, and JNK in cell lysate. (B) Expressions of p-IkB-α, and IkB in cell lysate. β-actin; loading control for cytosolic fractions.
(C) Expressions of NF-kB p65 in nuclear fractions. Lamin B; loading control for nuclear fractions. The images shown are representative of three independent
experiments. (D) The relative band intensity of each protein is expressed as a percentage. The data are shown as means ± SD (n = 3 samples). ***p < 0.001 for the
treatments compared with untreated DCs (0min). (E) The effects of MAP1981c on the cellular localization of the p65 subunit of NF-κB in DCs. The images shown are
representative of three independent experiments (scale bar = 5µm).
MAP1981c on the proliferation and differentiation of OVA-
specific CD4+ and CD8+ T cells using splenic T cells from OT-I
and OT-II mice (splenic CD8+ T cells of OT-I mice expressing
TCRs against OVA257−264 and splenic CD4
+ T cells of OT-II
mice expressing TCRs against OVA323−339). CD4
+ and CD8+
T cells co-cultured with MAP1981c-treated DCs proliferated
more than T cells co-cultured with non-treated DCs (Figure 9A).
Additionally, we investigated the induction of major factors
involved in the activation and differentiation of T cells exposed to
MAP1981c-treated DCs. CD4+ T cells primed with MAP1981c-
treated DCs produced high levels of IFN-γ and IL-2, important
for polarization and activation of Th1-type cells; on the other
hand, the expression of the Th2-type cytokine IL-4 was not
affected (Figure 9B, top panel). Similarly, CD8+ T cells primed
with MAP1981c-treated DCs produced high levels of IFN-γ and
IL-2 cytokines (Figure 9B, bottom panel). These results suggest
that MAP1981c-treated DCs can induce Th1 polarization in
naïve CD4+ T cells, and activate naïve CD8+ T cells.
MAP1981c Induces the Maturation of
Conventional DCs and Promotes
Generation of Th1-Type T Cells in Vivo
Based on the above in vitro results, we evaluated whether
MAP1981c can induce DC maturation, generation of Th1-
type T cells, and activation of T cells in vivo (Figure 10).
The in vivo experiment was performed as described in the
Materials and Methods section. MAP1981c-injected groups
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 10 June 2018 | Volume 8 | Article 206
Kim et al. MAP1981c-Activated DCs Induce Th1 Polarization
FIGURE 8 | Inhibition of MAP1981c-induced DC maturation via pharmacological inhibitors of MAPKs and NF-kB signals. Following pre-treatment with
pharmacological inhibitors (ERK; U0126, JNK; SP600125, p38; SB203580, NF-kB; Bay11-7082) for 1 h, cells were stimulated with MAP1981c (5µg/mL) for 24 h. (A,
left panel) Analysis of surface markers (CD80 and CD86) on stimulated CD11c+ DCs by using flow cytometry. The histograms shown are representative of three
independent experiments. (A, right panel) The MFI calculated from histograms is indicated as the mean ± SD of three independent experiments. **p < 0.01,
***p < 0.001 for the treatments compared with MAP1981c-treated DCs (MAP1981c). (B) The culture supernatants were analyzed for the amounts of TNF-α, IL-6, and
IL-1β by using ELISA. *p < 0.05, **p < 0.01, ***p < 0.001 for the treatments compared with MAP1981c-treated DCs (MAP1981c). U; U0126, SP; SP600125, SB;
SB203580, Bay; Bay11-7082.
showed increased surface molecule expression in splenic CD8α+
cDCs (CD8α+CD11c+) and CD8α− cDCs (CD8α−CD11c+)
compared with PBS-injected groups, indicating DC maturation
(Figure 10A). We also observed that the frequencies of Th1-
type T cells (IFN-γ−producing CD4+ T cells and T-bet-
expressing CD4+ T cells) and activated CD8T cells (IFN-
γ−producing CD8+ T cells) were generally increased in the
MAP1981c-injected groups compared with the PBS-injected
groups. However, no significant differences between PBS- and
MAP1981c-injected groups were observed for the frequency of
Th2-type T cells (IL-4−producing CD4+ T cells and GATA-
expressing CD4+ T cells; Figure 10B).
DISCUSSION
Mycobacterium avium subsp. paratuberculosis (MAP) is the cause
of gastroenteritis in ruminants and is linked to the pathology of
Crohn’s disease in humans. In the present study, we characterized
a putative DNA binding protein, MAP1981c, isolated from
cellular extracts of MAP human isolates, which is reactive
against the sera of patients with Crohn’s disease. We found that
MAP1981c contributes to the development of T cell-mediated
immunity through DC activation. MAP1981c recognizes TLR4,
and promotes DC maturation and activation via MyD88-
and TRIF-dependent pathways, followed by the activation of
MAP kinases and NF- κB. In addition, MAP1981c-treated DCs
activated naïve T cells and induced the differentiation of CD4+
and CD8+ T cells to express T-bet, IL-2, and IFN-γ, but not
GATA-3 and IL-4, thus inducing Th1-type immune responses
both in vitro and in vivo.
DCs are special antigen presenting cells that can lead
to immune responses by engaging both innate and adaptive
immunity, and are necessary for T cell activation and
differentiation (Lipscomb and Masten, 2002; Kim T. H. et al.,
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FIGURE 9 | Proliferation and cytokine production of T cells induced by MAP1981c-treated DCs. (A,B) DCs were treated with MAP1981c (5µg/mL) or LPS
(100 ng/mL). After 24 h treatment, cells were stimulated with OVA323−339 or OVA257−264 of 1µg/mL concentration for 1 h and then co-cultured with CFSE-labeled
OVA-specific CD4+ and CD8T cells. (A) After 3 days co-culture, cells were harvested and stained with anti-CD4 or CD8 Abs and then T cell proliferations were
analyzed by flow cytometry. The histograms shown are representative of three independent experiments. (B) The culture supernatants were analyzed for the amounts
of IFN-γ, IL-2, and IL-4 by using ELISA. All bar graphs show the means ± SD of 3 samples. One representative plot out of three independent experiments is shown;
*p < 0.05, **p < 0.01, ***p < 0.001 for the treatments compared with OVA-treated DCs (OVA323−339-treated DCs or OVA257−264-treated DCs).
2015). Therefore, it is important to study the mechanism through
which MAP antigen induces DC maturation as well as the
immune responses induced during MAP pathogenesis. MAP-
infected macrophages or DCs travel to the draining lymph
nodes, and the interaction of migrated cells with T cells is
important for an appropriate immune response: the T cell-
mediated immune response can induce infected macrophages
to eliminate intracellular bacteria or kill infected macrophages
(Koets et al., 2015). The progression of mycobacterial infection
has been proposed to be linked to the Th1/Th2 shift in the host
(Magombedze et al., 2014). The infected animals initially exhibit
a cell-mediated CD4+ T cell response to MAP, characterized
by the production of interferon-γ (Th1 response); however, as
the disease progresses, the Th1 response diminishes while the
antibody response to MAP (Th2 response) increases. Therefore,
the conversion from Th1 to Th2 response occurs simultaneously
with disease progression and bacterial excretion (Magombedze
et al., 2014). Interestingly, Th1-inducible mycobacterial antigens
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FIGURE 10 | Induction of the splenic DC maturation and promotion of Th1-type cells by in vivo injection of MAP1981c. C57BL/6 mice (5 mice per group) were
injected IV with 5 mg/kg MAP1981c or PBS and were analyzed 24 h later. (A) Single cells prepared from splenocytes of mice were stained with the Live/Dead (L/D) kit,
anti-CD11c, anti-CD8α, anti-CD80, anti-CD86, anti-MHC-I, and anti-MHC-II Abs. The graphs show the expression levels of CD80, CD86, MHC-I, and MHC-II in
CD8α+CD11c+ and CD8α−CD11c+ cells. All bar graphs show the means ± SEM from two independent experiments. (B) Mice (5 mice per group) of each group
were injected with MAP1981c (5 mg/kg) or PBS, and after 3 days, were injected with MAP1981c (5 mg/kg) or PBS again. Single cells prepared from splenocytes of
mice were stimulated with anti-CD3/CD38 Abs in the presence and absence of GolgiPlug for 12 h, and then the cells were stained L/D kit, anti-CD3, anti-CD4,
anti-IFN-γ, anti-IL-4, anti-T-bet, and anti-GATA-3 Abs and analyzed by flow cytometry. The graphs show the expression levels of IFN-γ, IL-4, GATA-3, and T-bet in
CD3+CD4+ or CD3+CD8+ T cells. All bar graphs show the means ± SEM from two independent experiments. n.s, No significant effects, *p < 0.05, **p < 0.01,
***p < 0.001.
may be useful as vaccine and diagnostic antigens during the
early infectious stages, since the Th1/IFN-γ response has been
demonstrated as a key factor in controlling mycobacterial
infection (Moliva et al., 2017).
Recently, several MAP antigens have been studied because of
their immunological role in theDC-mediated immune responses.
A study has found that a MAP fibronectin attachment protein
(ModD) and MAP1305 induce Th1-type responses by activating
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DCs, and the response is induced through toll-like receptor 4
(TLR4) (Lee et al., 2009, 2014). Ag85, CobT (35-kDa protein),
and malate dehydrogenase, all produced by MAP, are T cell
immune modulating antigens leading to T cell proliferation and
IFN-γ production (Rosseels et al., 2006; Byun et al., 2012; Kim
et al., 2018). Additionally, the 70 kDa heat shock protein of
MAP can induce DC maturation and activation through the NF-
κB and MAPK signaling, confirming the induction of protective
immune responses to MAP through T cell polarization (Hoek
et al., 2010). On the contrary, Basler et al. showed inhibition of
DC maturation and induction of a tolerogenic DC phenotype
with lowered expression of MHCII, CD86, and TNF-αwhen DCs
were treated with supernatants fromMAP-infectedmacrophages.
However, when DCs were infected with MAP, the same authors
confirmed induction of DC maturation, followed by decreased
IL-12 and increased IL-10 production (Basler et al., 2013). In this
respect, MAP could induce DC maturation as well as tolerogenic
immune responses. Nevertheless, several MAP antigens, capable
of induction of DC maturation and Th1 immune responses, may
be potentially useful for vaccine production or as diagnostic tools.
In the present study, recombinant MAP1981c was produced
and analyzed for its immunological role on DCs. DCs are
involved in the initiation of the immunopathological reaction;
after the migration of activated DCs to the lymphoid organs,
the DCs ultimately induce antigen-specific T cell responses
(Choi et al., 2015). The results of the present study showed
that MAP1981c induced activation and maturation of DCs,
manifested by the increased expression of cell surface markers
such as co-stimulatory signals (CD80, CD86), MHC class I
and II and pro-inflammatory cytokines including TNF-α, IL-
6, IL-1β, and IL-12p70, and decreased antigen uptake capacity
(Figures 2, 3, 5). TLR2 and TLR4 play an important role in
the initial recognition of mycobacterial antigens in macrophages
and DCs, which are known to affect innate and acquired
immunity (Carmona et al., 2013). Recently, it has been reported
that a TLR4 agonist may play an important role as an
immunomodulator in the treatment of cancer (Jung et al., 2011).
Moreover, the study has shown that signals from MyD88- and
TRIF-dependent pathways are particularly strong immunological
stimuli (Jung et al., 2011). MAP1981c interacted with TLR4 and
induced the activation ofMyD88- and TRIF-dependent pathways
and MAPK and NF-κB signaling pathways (Figures 6, 7), which
are associated with the maturation of DCs and the expression of
proinflammatory cytokines (Rescigno et al., 1998; Kim J. S. et al.,
2015). DC activation by MAP1981c induced naïve CD4+/CD8+
T cell proliferation and prompted CD4+ and CD8+ T cells to
express T-bet, IL-2, and IFN-γ, but not GATA-3 and IL-4, thus
inducing Th1-type immune responses both in vitro and in vivo
(Figures 9, 10).
As indicated above, we decided to focus on MAP1981c in this
study because of its strong immune response in both patients
with Crohn’s disease and cattle with Johne’s disease. Similarly,
in calves challenged with MAP, Facciuolo et al. found a stronger
antibody reactivity for MAP1981c 2 months post infection (PI)
than 1 month PI and pre-infection (Facciuolo et al., 2016). Here,
we demonstrated that MAP1981c can induce DCmaturation and
activation and a Th1-type immune response. Consequently, our
study shows that MAP1981c could be a novel immunocompetent
antigen that induces Th1 cell polarization through its interaction
with DCs, suggesting that MAP1981c may be a new target for
MAP vaccine production and MAP infection diagnosis.
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